Baloira, Adolfo http://orcid.org/0000-0003-3944-084X
Gonzalez-Moro, José Miguel Rodriguez
Sanjuán, Estefanía
Trigueros, Juan Antonio
Casamor, Ricard
Funding for this research was provided by:
Novartis Farmacéutica
Article History
Received: 8 October 2018
Accepted: 21 November 2018
First Online: 3 December 2018
Ethics approval and consent to participate
: This study was conducted in accordance with the ICH Harmonised Tripartite Guidelines for Good Clinical Practice, with applicable local regulations (including the European Directive 2001/83/EC and U.S. Code of Federal Regulations Part 21), and with the ethical principles established in the Declaration of Helsinki. The study protocol was reviewed and approved by the Institutional Review Board of Complejo Hospitalario de Toledo (23 December 2014, protocol number 156). All participants provided written informed consent.
: Not applicable.
: AB has participated as a consultant in meetings sponsored by Novartis, Boehringer Ingelheim, GSK, Astra, Esteve Laboratories and TEVA and has received grants from GSK, Novartis, Boehringer Ingelheim and Esteve Laboratories. JMRG-M has received consultancy and speaker fees from Boehringer-Ingelheim, Novartis, Rovi and GSK. ES has received speaker fees from Chiesi, Novartis, Pfizer; consultancy fees from Novartis, Almirall, GSK, Orion; sponsorship to travel to scientific meetings from Chiesi, Teva, Rovi, Mundipharma and Boehringer. JAT has received consultancy and speaker fees from AstraZeneca, Boehringer Ingelheim, Teva, Menarini and Novartis. RC is a full time employee of Novartis Farmaceutica SA.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.